Luxbright AB

LXB · ST · Healthcare / Medical Devices

6.24SEK-0.02 (-0.32%)

Price History

Full chart

Market Stats

Previous Close6.26

Open6.15

Day Range6.02 – 7.50

52-Week Range0.032 – 0.756

Volume7.09K

Market Cap8.75M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.15

Dividend Yield0.00%

Beta-0.10

50-Day Avg0.0663

200-Day Avg0.2227

About

Luxbright AB (publ), a technology company, develops, manufactures, and sells microfocus x-ray tubes and sources for industrial and non-destructive testing applications worldwide. It also provides Luxbright IX1, an integrated x-ray source product; and custom-made x-ray tubes. Luxbright AB (publ) was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Patrik Hallberg
Employees11
HeadquartersHulda Lindgrens gata 6B, Västra Frölunda, Sweden, 421 31, Sweden
Websitehttps://www.luxbright.com

Leadership

Mr. Patrik HallbergChief Executive Officer · b. 1980
Magnus ErlandssonChief Financial Officer
Mr. Goran ZelanderC.C.O · b. 1974
Ms. Liping MoSuzhou Luxbright CMD

Financials

Income Statement

Currency: SEK	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	84.97K	728.52K	1.22M	1.40M	703.68K	614.29K	729.00K	811.70K	854.70K	9.02M	11.41M
Growth (%)	-	+757.38%	+67.97%	+14.43%	-49.75%	-12.70%	+18.67%	+11.34%	+5.30%	+955.58%	+26.52%
Cost of Revenue	1.96M	14.83K	17.24K	-1.40M	-1.47M	-959.64K	-1.25M	622.58K	3.65M	144.00K	32.78M
Gross Profit	-1.88M	713.69K	1.21M	2.80M	2.18M	1.57M	1.98M	189.12K	-2.80M	8.88M	-21.37M
Gross Margin	-2207.85%	97.96%	98.59%	200.00%	309.51%	256.22%	271.86%	23.30%	-327.28%	98.40%	-187.20%
Operating Expense	-3	6.30M	13.10M	14.88M	12.73M	13.87M	20.60M	21.71M	23.24M	26.94M	0
Operating Income	-1.88M	-5.58M	-11.90M	-12.08M	-10.55M	-12.29M	-18.62M	-21.52M	-26.03M	-18.06M	-21.37M
Operating Margin	-2207.85%	-766.22%	-972.23%	-862.71%	-1499.14%	-2001.14%	-2553.85%	-2651.67%	-3046.03%	-200.17%	-187.20%
EBITDA	-1.52M	-2.85M	-7.18M	-12.06M	-10.52M	-12.18M	-17.63M	-20.47M	-23.87M	-15.72M	-16.76M
EBITDA Margin	-1783.47%	-390.68%	-586.49%	-861.39%	-1494.37%	-1982.36%	-2418.75%	-2521.48%	-2792.41%	-174.24%	-146.81%
Net Income	-1.55M	-3.12M	-6.94M	-12.26M	-10.65M	-12.38M	-18.10M	-21.13M	-25.38M	-17.72M	-19.46M
Net Income Margin	-1818.60%	-427.73%	-566.98%	-875.41%	-1514.10%	-2015.86%	-2482.59%	-2603.66%	-2968.90%	-196.38%	-170.51%
R&D	-	359.24K	836.91K	552.27K	-	-	-	-	-	-	-
R&D as % of Total Revenue	-	49.31%	68.39%	39.44%	-	-	-	-	-	-	-
Interest Expense	21.32K	-	0	177.87K	105.25K	90.46K	91.93K	19.00K	22.88K	12.80K	390.53K
Interest Expense % of Total Revenue	25.09%	-	0.00%	12.70%	14.96%	14.73%	12.61%	2.34%	2.68%	0.14%	3.42%

Balance Sheet

Currency: SEK	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	4.82M	12.95M	9.55M	15.06M	15.44M	44.11M	23.99M	31.19M	40.69M	42.66M	39.38M
Total Liabilities	2.44M	13.62M	15.50M	8.16M	4.94M	5.47M	3.36M	3.33M	7.00M	8.46M	12.49M
Total Equity	2.38M	-667.16K	-5.94M	6.90M	10.50M	38.64M	20.63M	27.86M	33.69M	34.20M	26.89M
Cash	1.94M	8.70M	3.98M	8.11M	6.34M	29.51M	7.51M	7.60M	14.04M	12.36M	5.29M
Total Debt	800.00K	1.80M	10.75M	2.47M	2.06M	1.81M	1.10M	588.34K	206.02K	254.19K	4.56M
Net Debt	-1.14M	-6.90M	6.77M	-5.64M	-4.27M	-27.71M	-6.41M	-7.01M	-13.83M	-12.36M	-738.96K

Cash Flow

Currency: SEK	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-13.67M	-11.15M	-13.47M	-13.67M	-17.14M	-20.64M	-20.39M	-16.52M	-19.87M
Investing Cash Flow	-	-3.42M	-1.55M	-2.15M	-3.42M	-4.15M	-7.15M	-3.99M	-3.44M	-3.65M
Financing Cash Flow	-	40.26M	16.83M	13.85M	40.26M	-708.00K	27.88M	30.82M	18.28M	16.46M
Capital Expenditure	0	0	1.55M	2.20M	0	0	0	0	0	19.87M
Free Cash Flow	-	-	-12.70M	-15.67M	-13.67M	-17.14M	-20.64M	-20.39M	-16.52M	-19.87M
FCF to OCF	-	-	113.91%	116.33%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

Key Statistics & Ratios

Market Cap8.75M

Enterprise Value8.27M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.92

Price / Book0.44

EPS-0.15

Book Value0.207

Revenue (TTM)9.50M

Gross Profit (TTM)6.35M

EBITDA-18.69M

Profit Margin-228.71%

Operating Margin-345.97%

Return on Equity-72.31%

Return on Assets-32.62%

Shares Outstanding206.42M

Shares Float153.72M

Beta-0.10

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Oct 15, 20261:100
Apr 13, 2026558:539
Feb 6, 2023166:163